|
Fluperlapine (NB 106-689), also known as fluoroperlapine, is a tricyclic atypical antipsychotic with additional antidepressant and sedative effects. It was first synthesized in 1979, and then subsequently studied in animals and humans in 1984 and beyond,〔 〕 but despite demonstrating efficacy in the treatment of a variety of medical conditions including schizophrenia,〔 〕〔 〕〔 〕〔 〕 psychosis associated with Parkinson's disease, depressive symptoms, and dystonia,〔 〕 it was never marketed.〔 This was perhaps due to its capacity for producing potentially life-threatening agranulocytosis, similarly to clozapine, which it closely resembles both structurally and pharmacologically. Binding profile == See also == * Clozapine 抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Fluperlapine」の詳細全文を読む スポンサード リンク
|